Zydus Lifesci.

ZYDUSLIFE19 Apr 2024
Pharmaceuticals
-14.10 (-1.51%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Zydus Lifesci.
Zydus Lifesci.
Pharmaceuticals
ZYDUSLIFE19 Apr 2024
-14.10 (-1.51%)
1D
1M
6M
1Y
5Y
All

Zydus Lifesci. - Share Price & Details

Lowest Today
913.25
Highest Today
933
Today’s Open
929.3
Prev. Close
936.3
52 Week High
1031.3
52 Week Low
482.55
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
78.27%
Upper Circuit
Lower Circuit
P/E TTM
34.53
P/B Ratio
6.36
Traded Value(Cr)
0.02
EPS TTM
26.71
Book value
Dividend
0.65%

Price Performance

-4.07 %
1 Wk
-4.89 %
1 M
28.11 %
3 M
78.27 %
1 Y
32.07 %
YTD

Traded Volume Movement

Technical Details

Support 3
893
Support 2
903
Support 1
913
Pivot Point :
923
Resistance 1
933
Resistance 2
943
Resistance 3
953

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Zydus Lifesciences Ltd
₹922.20(-14.10/-1.51%)
922.20-14.1092,794.9078.2734.536.36
Astrazeneca Pharma India Ltd
₹5,172.20(-32.50/-0.62%)
5,172.20-32.5012,930.5061.4881.0719.74
Cipla Ltd
₹1,345.35(-2.30/-0.17%)
1,345.35-2.30108,622.8847.5633.034.20
Bliss GVS Pharma Ltd
₹109.65(-1.20/-1.08%)
109.65-1.201,147.9343.0916.821.17
Abbott India Ltd
₹26,131.85(+76.20/0.29%)
26,131.85+76.2055,530.1814.9548.4717.86
Amrutanjan Health Care Ltd
₹637.90(-6.05/-0.94%)
637.90-6.051,844.212.2541.917.04

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 92794.9 crores. It has reported a sales of Rs. 2225.1 crores and a net profit of Rs. 450.4 crores for the quarter ended December 2018. The company management includes Pankaj R Patel, Pankaj R Patel,Sharvil P Patel,Mukesh M Patel,Nitin Raojibhai Desai,Dharmishta N Rawal,Apurva S Diwanji,Ganesh N Nayak,Bhadresh K Shah,Dhaval N Soni,Akhil A. Monappa,Upasana Konidela. (Zydus Lifesciences Ltd) among others.
Chairman
Pankaj R Patel
Registered office
Zydus Corporate Park S No 536,Khoraj Sarkhej-Gandhinagar H/W,Ahmedabad,Gujarat,382481
FAX :91-079-26868337/26862365/26862366
Background
Incorporation Year1995
Face Value₹1
Market Lot1

Latest News

✅Sensex surges 599 points at the close; Nifty near 22,150
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 599.34 points or 0.83% at 73,088.33, and the Nifty was up 151.15 points or 0.69% at 22,147.00.
📊Among sectoral, Nifty Bank (⬆️1.07%) turned out to be the best performer while Nifty Pharma (⬇️0.65%) saw considerable selling.
19 Apr 2024 | 03:40 PM
NSE to launch Nifty Next 50 F&O
The National Stock Exchange of India (NSE) on Thursday announced the launch of futures and options contracts (F&O) on Nifty Next 50 index. The move is likely part of a series of steps being taken by the India’s largest stock exchange to regain some of the market share it lost to rival BSE over the last year. NSE will launch monthly F&O contracts on the junior Nifty 50 index from April 24.
19 Apr 2024 | 01:06 PM
Mid-day Mood | Market trades in red as Middle-East crisis deepens
Sensex and Nifty trimmed earlier losses but continued to trade in the red on April 19 amid a broad-based selloff. Investors traded on the sidelines after Israel's attack on Iran fuelled uncertainity across market. As a result, fear gauge India VIX jumped over 4%. Around noon, the Sensex was down 244.94 points or 0.34% at 72,244.05, and the Nifty was down 80.10 points or 0.36% at 21,915.70.
19 Apr 2024 | 12:53 PM
📢 Sensex plunges 618 points at the open; Nifty below 21,830
📈 Amid weak global cues, domestic benchmark indices started gap-down on 19-April-2024
📢 At 9:16 AM, the Sensex tanked 617.64 points or 0.85% at 71,871.35, and the
Nifty plunged 182.80 points or 0.83% at 21,813.05.
📊 Hind Petro (⬇️3.38%), BPCL (⬇️3.32%) and IOC (⬇️2.63%) appeared as the top losers on the Nifty 50 at the Open. ONGC, Cipla and M&M stocks are in focus today.
19 Apr 2024 | 09:23 AM
✅Sensex surges 599 points at the close; Nifty near 22,150
✅ Amid positive global cues, benchmark indices closed on a positive note today.
📢 At 3:30 PM, the Sensex improved by 599.34 points or 0.83% at 73,088.33, and the Nifty was up 151.15 points or 0.69% at 22,147.00.
📊Among sectoral, Nifty Bank (⬆️1.07%) turned out to be the best performer while Nifty Pharma (⬇️0.65%) saw considerable selling.
19 Apr 2024 | 03:40 PM

How to buy Zydus Lifesci. shares on nse?

To buy Zydus Lifesci. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Zydus Lifesci. share price today?

The Zydus Lifesci. shares price on nse is Rs.922.2 today.

What is the market cap of Zydus Lifesci. shares on BSE ?

The company has a market capitalization of Rs.92794.90Cr

What is the PE & PB ratio of Zydus Lifesci. shares ?

PE is 34.53 and PB is 6.36

What is the 52 Week High and Low of Zydus Lifesci. shares?

Zydus Lifesci. stock price high: Rs.1031.3 Zydus Lifesci. stock price low: Rs.482.55

What is Zydus Lifesciences' stock forecast?

With a new 52-week high, the Zydus Lifesciences stock is expected to outperform in the near term. The average target as of May 11, 2023, is Rs. 521 – a 1.41% increase from the current price of Rs. 513.75.

What is Zydus Lifesciences stock's highest price ever?

The highest price ever for Zydus Lifesciences was Rs. 650.50 on 4th June 2021. 

What is the Zydus Lifesciences stock price target for 2023?

The average stock target price of Zydus Lifesciences for 2023 is currently at Rs. 521 although some brokerages reckon it could go closer to Rs. 600. 

Does Zydus Lifesciences have a solid foundation?

Zydus Lifesciences has a solid foundation that has triggered its recent bullish run. It has a strong presence in the pharmaceutical industry and has been operating for several decades in the development, manufacturing, and marketing of a wide range of healthcare products, including pharmaceuticals, diagnostics, herbal products, and wellness products. With a recent FDA clearance on a pulmonary drug and better-than-expected Q3 profits, Zydus has shown stable and reliable growth. 

What is the Zydus Lifesciences stock dividend payout date?

Zydus Lifesciences is expected to pay its stock dividend in July. The company consistently paid dividends in July for the past two years.

What is the most recent Zydus Lifesciences stock news?

Zydus received the USFDA nod to manufacture and market drugs for osteoporosis, ulcer, blood pressure, heart disease, and pulmonary infections, and general anti-inflammatories. Furthermore, it is looking to sell its clinical research business for close to USD 200 million.